Important information regarding cookies and
By using this website, you consent to the use of cookies in accordance with the IMB Cookie Policy. For more information on cookies, see our Cookie Policy.
Full Version | Search

The Irish Medicines Board -

IMB Logo

Fourth DHPC on Ketoprofen - Important Safety Information from A.Menarini Pharmaceuticals as approved by the Irish Medicines Board

07 December 2011

Important Safety Information from A. Menarini Pharmaceuticals on risk minimisation measures for ketoprofen-containing topical formulations.

Important Safety Information - Ketoprofen

Note that this is the fourth DHPC from A.Menarini Pharmaceuticals on this issue as part of a commitment to continued risk minimization as agreed with the EMA; the first DHPC on Ketoprofen-containing topical formulations was issued in August 2010; the second DHPC on Ketoprofen-containing topical formulations was issued in December 2010; the third DHPC on Ketoprofen-containing topical formulations was issued in July 2011.

Date Printed: 21 April 2014

© Irish Medicines Board 2014 | Developed by Engine Solutions

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971